General Announcement::CHANGE IN COMPOSITION OF THE BOARD OF DIRECTORS AND BOARD COMMITTEES

Issuer & Securities

Issuer/ Manager
HYPHENS PHARMA INTERNATIONAL LIMITED
Securities
HYPHENS PHARMA INTL LIMITED - SG1EE4000006 - 1J5
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
17-Apr-2020 17:55:06
Status
New
Announcement Sub Title
CHANGE IN COMPOSITION OF THE BOARD OF DIRECTORS AND BOARD COMMITTEES
Announcement Reference
SG200417OTHRJC07
Submitted By (Co./ Ind. Name)
Lim See Wah
Designation
Executive Chairman & CEO
Description (Please provide a detailed description of the event in the box below)
Please refer to the attached.

This announcement has been prepared by the Company and its contents have been reviewed by the Sponsor, DBS Bank Ltd. ("Sponsor") for compliance with the Singapore Exchange Securities Trading Limited ("SGX-ST") Listing Manual Section B: Rules of Catalist. The Sponsor has not verified the contents of this announcement.

This announcement has not been examined or approved by the SGX-ST. The SGX-ST assumes no responsibility for the contents of this announcement including the accuracy, completeness or correctness of any of the information, statements or opinions made or reports contained in this announcement.

The contact persons for the Sponsor are Ms Heng Mui Mui, Managing Director, and Mr Kelvin Wong, Senior Vice President, who can be contacted at 12 Marina Boulevard, Level 46, Marina Bay Financial Centre Tower 3, Singapore 018982, Telephone: +65 6878 8888.

Attachments

HPIL - Annt_Change in board composition_170420.pdf
Total size =138K